Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by MementoMorion Jan 08, 2009 3:11pm
617 Views
Post# 15691958

RE: RE: RE: RE: UBS Securities

RE: RE: RE: RE: UBS SecuritiesI apologize for repeating myself but: Claims of some internationally-based evil force manipulating this stock are just silly at the current volume. The average volume so far in 2009 is 80,000 shares per day, which are worth about CAN$10,000 at 0.13 per share.

There is no need to manipulate the price to keep it down; it is down because there are presently no motivated buyers. Let us hope that may yet change.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities